Skip to main content
Fig. 5 | Breast Cancer Research

Fig. 5

From: Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer

Fig. 5

Validation of genes identified using microarray. MCF7 and TAMR cells were transfected with silencer negative control siRNA, ATF2 siRNA1 and ATF2 siRNA2. qRT-PCR was carried out using Taqman primers for the genes indicated. Data analysis for each cell line was carried out relative to the siControl (n = 3) and asterisks indicate the genes that were significantly changed after ATF2 knockdown (*p < 0.05, **p < 0.005)

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us